L02BB Anti-androgens

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L02BB
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L02BB

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 1532 - 1532
Unadjusted prevalence (%) 0.59 - 1.35
Mean age at first event (years) 70.64 - 70.64

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: RX_L02BB – L02BB Anti-androgens
GWS hits:

Survival analyses between endpoints

Plot

before L02BB Anti-androgens
after L02BB Anti-androgens

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L02BB Anti-androgens